Thank you for joining us! Our Webinar will begin shortly.
|
|
- Neil Atkins
- 5 years ago
- Views:
Transcription
1 Complementary HILIC Techniques for the Successful Characterization of Therapeutic Protein Glycosylation Thank you for joining us! Our Webinar will begin shortly. While you are waiting, please feel free to browse our library of Webinar content: Click below to learn more about our NEW GlycoWorks RapiFluor-MS N-Glycan Analysis Kit and our NEW ACQUITY UPLC Glycoprotein BEH Amide 300Å 1.7 µm Columns Waters Corporation 1
2 Friendly Reminders Please use text chat functionality to submit questions during the Webinar. Upon conclusion, follow up information will be available: Recorded version of today s presentation PDF Copies of today s slides Product specific information / Reference materials Discount Offers - GlycoWorks RapiFluor-MS N-Glycan Analysis Kits ACQUITY UPLC Glycoprotein BEH Amide 300Å 1.7 µm Columns 2015 Waters Corporation 2
3 Today s Presenter Matthew Lauber, Ph.D. Waters Corporation, Milford, MA USA Matthew Lauber is a Principal Applications Chemist within the Consumables Business Unit at Waters Corporation, where he applies his expertise in protein chemistry and LC-MS based protein characterization methods toward the development and application of state-of-the-art reagents and separation chemistries. Most recently, Matthew has led investigations into the rapid and sensitive analyses of released N- glycans as well as the development of new strategies for characterizing protein glycosylation that are based on the use of a widepore HILIC column technology Waters Corporation 3
4 Complementary HILIC Techniques for the Successful Characterization of Therapeutic Protein Glycosylation Matthew A. Lauber, Ph.D Waters Corporation 4
5 Glycosylation of Biotherapeutics Fucose GlcNAc Mannose Effector Functions (ADCC/CDC) (fucosylation/galactosylation) Low Half Life (high g mannose) Anti-Inflammatory (sialylation) Immunogenic (αgal / N-glycolylneuraminic gy y acid) Overall profile sensitive to manufacturing conditions Galactose N-acetylneuraminic acid N-glycolylneuraminic acid N-glycosylation is a quality attribute of biotherapeutics N-glycan profiles are frequently characterized in detail and routinely monitored Anal Chem 2013, 85 (2), Waters Corporation 5
6 Glycoprotein Characterization Multiple Strategies Complementary Information 2015 Waters Corporation 6
7 Released Glycan Analysis HILIC Profiling Conventional 5 Hours to 2 Days Conventional 2+ 2-AB 5.3e2 FLR m/z 2015 Waters Corporation 7
8 RapiFluor-MS Reagent Rapid Labeling Kinetics From Waters expertise in rapid, fluorescence labeling of amino acids Enhanced chemical properties for glycan analysis: Rapid Tagging Efficient Fluorescence Enhanced Ionization Efficiency RapiFluor-MS AccQ Fluor Rapid Fluorescence Anal Chem 2015, 87 (10), Patent Pending 2015 Waters Corporation 8
9 RapiFluor-MS Reagent Rapid Labeling Kinetics Mechanism for Rapid Tagging of Glycosylamines with RapiFluor-MS NHS Carbamate Rapid Tagging Group rapifluor-ms Tertiary Amine MS Charge Tag + Δmass (glycosylamine) Glycosylamine = Da (reducing end) = Da +C 17 H 20 N 4 O 2 Δtime = Quinoline Fluorophore Monoisotopic mass shift (from glycosylamine) seconds 1586 Da H 2 O CO 2 Anal Chem 2015, 87 (10), Patent Pending 2015 Waters Corporation 9
10 Revolutionizing N-Glycan Sample Prep Sensitivity Fluorescence MS (BPI) RapiFluor-MS Labeled Instant AB Labeled 2-AB Labeled Procainamide Labeled ve Performan nce (%) Relati * * (*) Comparative result extrapolated from a published comparison of N-glycans, gy wherein it was found that procainamide provided comparable fluorescence and up to 50 fold greater ESI-MS sensitivity when compared to 2-AB(Klapoetke et al. 2010). Anal Chem 2015, 87 (10), Patent Pending 2015 Waters Corporation 10
11 Simplified Workflow Conventional 5 Hours to 2 Days Direct Analysis (Organic Solvent Dilution) 10 min 5 min 10 min GlycoWorks RapiFluor-MS N-Glycan Kit Total Sample Prep Time 30 min Anal Chem 2015, 87 (10), Patent Pending 2015 Waters Corporation 11
12 Glycan Characterization Detailing the N-Glycan Profile of a mab 2.1E+6 FLR Intact mab Mass Check Standard anti-citrinin murine monoclonal IgG1 0.0E+6 8.4E+6 MS Rapid Preparation Deglycosylation l Labeling SPE 30 min , E+6 FA2G2Ga1 Anal Chem 2015, 87 (10), Patent Pending Example courtesy of Y. Yu 2015 Waters Corporation 12
13 Glycan Characterization Detailing the N-Glycan Profile of a mab 2.1E+6 FLR Intact mab Mass Check Standard anti-citrinin murine monoclonal IgG1 0.0E+6 8.4E+6 MS Peak Obs Mass Mass Error Approximate Glycan Name No. (M+H) + (ppm) Relative% 1 A FA A FA A2G FA1G < E+6 6 A2G1(iso) FA2G FA2G1(iso) FA2G1B FA2G1B (iso) FA2G FA2G1Ga F: Fucose 13 FA2G2Ga A: Antennary 14 FA2G2Sg G: Galactose B: Bisecting 15 FA2G2Sg1(iso) Anal Chem 2015, 87 (10), Ga: Alpha-galactose 16 FA2G2Ga Sg: N-glycolylneuraminic acid 17 FA2G2GaSg Patent Pending iso: Structural isomer 18 FA2G2Ga1Sg1(iso) Waters Corporation 13
14 GlycoWorks RapiFluor-MS N-Glycan Kit Preparation of labeled N-glycans (from glycoprotein to analysis ready sample) in 30 minutes Unprecedented sensitivity RapiFluor-MS N-glycan detection facilitated by combining RapiFluor-MS labeling and recent advances in mass spectrometry GlycoWorks RapiFluor-MS N-Glycan Kit Anal Chem 2015, 87 (10), Patent Pending 2015 Waters Corporation 14
15 gy Anal Chem 2015 DOI: /acs.analchem.5b New Application Notes on Released N-Glycan Analysis Genetic Engineering g News Webinars Broadcast: March 25, 2015 June 18, :00 AM EST Currently On Demand 2015 Waters Corporation 15
16 Glycoprotein Characterization Multiple Strategies Complementary Information HILIC Hydrophilic Interaction Chromatography 2015 Waters Corporation 16
17 Proof of Concept on Large Molecule HILIC RNase B High Mannose Man5 to Man9 PDB: 1RBB Glycan structure shown to scale with protein Modified from Structure 1999, 7 (7), R Waters Corporation 17
18 HILIC Stationary Phases A Unbonded BEH 130Å Time (min) 2015 Waters Corporation 18
19 HILIC Stationary Phases BEH Particle 0.4 A Amide Bonded BEH 130Å Unbonded BEH 130Å Increased Retentivity (>10% H 2 O) Improved Resolution Time (min) 2015 Waters Corporation 19
20 HILIC Stationary Phases Amide Bonded BEH 300Å Improved Resolution for Large Analytes Highly Branched Glycans 0.4 Intact mabs A Amide Bonded BEH 130Å Unbonded BEH 130Å Time (min) Patent pending 2015 Waters Corporation 20
21 HILIC Stationary Phases Amide Bonded BEH 300Å Improved Resolution for Large Analytes Highly Branched Glycans 0.4 Intact mabs A Amide Bonded BEH 130Å 130Å Unbonded BEH 130Å 300Å Time (min) Patent pending 2015 Waters Corporation 21
22 Method Development Mobile Phase Additive RNase B %FA 0.5% TFA A mm Ammonium Formate ph H F 3 C-COO - - OOC-CF % TFA F 3 C-COO - + H 3 N Time (min) - OOC-CF 3 Protonation and Strong Ion Pairing with a Hydrophobic Acid Hydrophilicity Reduced Minimize protein hydrophilicity Improve selectivity of the separation for the glycan Patent pending 2015 Waters Corporation 22
23 Orthogonality and LC-MS Man5 +Man6 +Man7 +Man8 +Man9 Reversed Phase BEH C4 300Å A RNase B aglycosylated Waters Corporation 23
24 Orthogonality and LC-MS Man5 +Man6 +Man7 +Man8 +Man9 Reversed Phase BEH C4 300Å A RNase B aglycosylated Man5 +Man6 HILIC BEH Amide 300Å A 214 RNase B aglycosylated +Man Man7 +Man Time (min) Patent pending 2015 Waters Corporation 24
25 Orthogonality and LC-MS Man5 +Man6 +Man7 +Man8 +Man9 Reversed Phase BEH C4 300Å A RNase B aglycosylated 0 Man9 Glycoform Man5 +Man6 HILIC BEH Amide 300Å A 214 RNase B aglycosylated +Man Man7 +Man Time (min) m/z Patent pending 2015 Waters Corporation 25
26 Glycoprotein Characterization Multiple Strategies Complementary Information HILIC Hydrophilic Interaction Chromatography 2015 Waters Corporation 26
27 Orthogonal Peptide Mapping Techniques Trastuzumab Lys-C Digest 1.0 Reversed Phase Peptide BEH C18 300Å 1.7 µm Non-glycosylated Peptides Peptide A HILIC A Glycoprotein BEH Amide 300Å 1.7 µm Non-glycosylated Peptides Glycopeptides Time (min) 2015 Waters Corporation 27
28 Orthogonal Peptide Mapping Techniques 0.2 Glycopeptides TKPREEQYNSTYRVVSVLTVLHQDWLNGK Peptide A Reversed Phase Same gradient slope HILIC A Time (min) Patent pending 2015 Waters Corporation 28
29 MS-Based Identification of Glycoforms as simple as peptide p mapping 0.07 FA2 UV FA2G1 HILIC HC:K16 TKPREEQYNSTYRVVSVLTVLHQDWLNGK Glycoforms Peptide A A2 FA1 M5 FA1G1 A2G1 FA2G1 FA2G2 A1 FA2 FA2G Da Da E+6 TIC Intensity 1E+6 HILIC 0E Time (min) Patent pending 2015 Waters Corporation 29
30 MS-Based Identification of Glycoforms as simple as peptide p mapping 0.07 FA2 UV FA2G1 HILIC HC:K16 TKPREEQYNSTYRVVSVLTVLHQDWLNGK Glycoforms Peptide A A2 FA1 M5 FA1G1 A2G1 FA2G1 FA2G2 FA2G2S , ppm A1 FA2 FA2G Da Da E+6 TIC m/z FA2G2S , ppm Intensity 1E+6 HILIC m/z 0E Time (min) Patent pending 2015 Waters Corporation 30
31 HILIC Glycopeptide Mapping to Investigate Multi-Domain Glycosylation g y y Cetuximab Lys-C / Tryptic Digest Peptide HILIC A Time (min) Patent pending 2015 Waters Corporation 31
32 HILIC Glycopeptide Mapping to Investigate Multi-Domain Glycosylation g y y Cetuximab Lys-C / Tryptic Digest 9 Fc glycoforms 16 Fab >2% Peptide T22 HILIC +FA2 T22 +FA2G1 HC:T22 EEQYNSTYR Glycoforms T8 +FA2G2Ga2 A 214 T8 +FA2G1 T22 +FA1 T8 +FA2G2 T22 +M5 T22 +FA1G1 T22 +FA2G1 T8 +FA2G2Sg1 T8 +FA2G2Ga1 T22 +M6 T22 +FA2G2 T8 +FA2G2Ga1Sg1 T22 +FA2G2Ga1 T22 +Hex6HexNAc3DHex1 HC:T8 MNSLQSNDTAIYYC(am)AR Glycoforms T8 T8 +Hex9HexNAc5DHex1 +Hex7HexNAc5DHex1NGNA1 T22 +Hex5HexNAc3DHex Time (min) T8 (deamidated) T8 +FA2G2Ga2 +FA2G2Sg2 T8 +Hex8HexNAc5DHex1 T8 +Hex8HexNAc5DHex1NGNA1 Patent pending 2015 Waters Corporation 32
33 Glycoprotein Characterization Multiple Strategies Complementary Information HILIC Hydrophilic Interaction Chromatography 2015 Waters Corporation 33
34 Middle-Up/Down mab Analysis Middle-Up (Fab )2 2x Light Chain 2x Fd Cleavage Site -G G- IdeS Digestion 2x Fc/2 Denaturation ti Reduction 2x Fc/ Waters Corporation 34
35 HILIC Middle-Up Analysis IdeS-Digested Trastuzumab g 0.24 Protein BEH C4 300Å 1.7μm Fc/2 Glycoforms 0.18 LC Fd Middle-Up A Time (min) 2015 Waters Corporation 35
36 HILIC Middle-Up Analysis IdeS-Digested Trastuzumab g UV Fd LC Fc/2 Middle-Up TIC 5 10 Patent pending 2015 Waters Corporation 36
37 HILIC Middle-Up Analysis IdeS-Digested Trastuzumab g UV Fd LC Fc/2 Middle-Up TIC Fc/2 +FA2 Fc/2 +FA2G Da Da Da A Fc/2 +A2 Fc/2 +A2G1 Fc/2 +FA2G1 Fc/2 +FA2G Time (min) Da Da Da Molecular Weight Da Patent pending 2015 Waters Corporation 37
38 Middle-Up Analysis Orthogonality 0.24 Protein BEH C4 300Å 1.7μm Fc/2 Glycoforms 0.18 LC Fd Middle-Up A Time (min) Glycoprotein BEH Amide 300Å 1.7μm LC 0.12 Fd A Fc/2 Glycoforms Time (min) Patent pending 2015 Waters Corporation 38
39 Glycoprotein Characterization Multiple Strategies Complementary Information HILIC Hydrophilic Interaction Chromatography 2015 Waters Corporation 39
40 Assaying Deglycosylation and Glycan Occupancy on Intact mabs Intact 2 N-Glycans 1 N-Glycans 0N-Glycans 2015 Waters Corporation 40
41 Assaying Deglycosylation and Glycan Occupancy on Intact mabs Detection Intr rinsic Fluo orescence Trastuzumab Partially Deglycosylated 2 N-Glycans 1 N-Glycan 21.5% 0 N-Glycans 3.1% min 2 N-Glycans 1 N-Glycans Intact 0N-Glycans Patent pending 2015 Waters Corporation 41
42 Assaying Deglycosylation and Glycan Occupancy on Intact mabs Trastuzumab (2 N-Glycans) Detection Intr rinsic Fluo orescence Trastuzumab Partially Deglycosylated 2 N-Glycans 1 N-Glycan 21.5% 0 N-Glycans 3.1% min Trastuzumab Native 2 N-Glycans FA2/FA2G Da FA2/FA2 148,057 Da 1,000 5,000 m/z kda Trastuzumab (1 N-Glycan) FA2 146,614 Da FA2G1 146,773 Da Intact 1 N-Glycan 1.0% min 1,000 5,000 m/z kda Patent pending 2015 Waters Corporation 42
43 Assaying Deglycosylation and Glycan Occupancy on Intact mabs Intrinsic Fluorescence Detection Intact Bevacizumab 1N-Glycan 4.9% Trastuzumab 1N-Glycan 1.0% IgG1κ Reference Material 1 N-Glycan 13% 1.3% Murine IgG1 (Intact mab Mass Check Std) 1 N-Glycan 0.7% min Patent pending 2015 Waters Corporation 43
44 Glycoprotein Characterization Multiple Strategies Complementary Information Increasing Peak Capacity for High Antennarity Released N-Glycans 2015 Waters Corporation 44
45 Increasing Peak Capacity for High Antennarity Released N-Glycans 3E+6 Glycan BEH Amide 130Å 1.7 µm 1 A2 2 P * c = 104 ΔRT 1,4 = min W h,avg = 7.43 sec 6 P * c = 53 ΔRT 5,8 = 6.45 min W h,avg = 7.47 sec W h 2 FA2G1 3 FA2G2S E Retention Time (min) 4 FA2BG2S2 3E+6 Glycoprotein BEH Amide 300Å 1.7 µm 5 - FA3G3S3 2 P c * = 101 ΔRT 1,4 = min W h,avg = 6.89 sec 6 P c * = 62 ΔRT 5,8 = 6.70 min W h,avg = 6.60 sec 6 - FA4G4S % Increase in Peak Capacity 7 - FA4G4Lac1S4 5 1x 0E FA4G4Lac2S Retention Time (min) 2x 2015 Waters Corporation 45
46 Increasing Peak Capacity for High Antennarity Released N-Glycans 3E+5 Glycan BEH Amide 130Å 1.7 µm FA3G3S3 6 - FA4G4S4 0E Glycoprotein BEH Amide 300Å 1.7 µm 3E x 7 - FA4G4Lac1S4 2x 8 - FA4G4Lac2S4 FA4G4S3 FA4G4S2 FA4G4Lac1S3 0E Retention Time (min) 2015 Waters Corporation 46
47 Glycoprotein Characterization Multiple Strategies Complementary Information Combining Approaches for Comprehensive Characterization 2015 Waters Corporation 47
48 Cetuximab Complementary Analyses p y y RapiFluor-MS Labeled N-Glycans Glycan BEH Amide 2.1 x 50 mm 4E+6 FA2 FA2G1 FA2G2Ga2 High Resolution High Sensitivity Released N-Glycan Profile EU M5 FA2G2 FA2G2Sg1 FA2G2Ga1 FA2G2Ga1Sg1 Hex9HexNAc5DHex1 Released Glycan 0E Time (min) Patent pending 2015 Waters Corporation 48
49 Cetuximab Complementary Analyses p y y RapiFluor-MS Labeled N-Glycans Glycan BEH Amide 2.1 x 50 mm 4E+6 FA2 FA2G1 FA2G2Ga2 High Resolution High Sensitivity Released N-Glycan Profile EU M5 FA2G2 FA2G2Sg1 FA2G2Ga1 FA2G2Ga1Sg1 Hex9HexNAc5DHex1 Released Glycan 0E Fc/2 +FA2 Time (min) Fc/2 Glycosylated Domain-Specific Glycan Information Fab Reduced, IdeS-Digested Cetuximab (Carboxypeptidase B treated) Glycoprotein BEH Amide 2.1 x 150 mm A Fc/2 +M5 Fc/2 +FA2G1 Fd pe + (FA2G2Sg1) Fd pe + (FA2G2Ga2) Fd pe + (FA2G2Ga1Sg1) Fd Glycosylated N-term pe N-Linked Glycans 0.02 Fc/2 +FA2G2 Fd pe + (Hex9HexNAc5DHex1) Fc Fd pe + (FA2G2Ga1) Middle-Up Time (min) Patent pending 2015 Waters Corporation 49
50 Characterization of EPO N and O-Linked Glycosylation y APPRLICDSR VLERYLLEAK EAENITTGCA EHCSLNENIT VPDTKVNFYA N-Linked Glycans WKRMEVGQQA VEVWQGLALL SEAVLRGQAL LVNSSQPWEP LQLHVDKAVS O-Linked Glycan GLRSLTTLLR ALGAQKEAIS PPDAASAAPL RTITADTFRK LFRVYSNFLR GKLKLYTGEA CRTGD O-Linked Glycan EPO Recombinant Human Epoetin Alpha N-Linked Glycans 2015 Waters Corporation 50
51 Released Glycan Analysis of EPO RapiFluor-MS Labeling 3E+6 Fluorescence Glycoprotein BEH Amide 2.1 x 150 mm N-Linked Glycans Released Glycan 0E+0 2E+5 BPI 0E Patent pending 2015 Waters Corporation 51
52 Released Glycan Analysis of EPO RapiFluor-MS Labeling 3E+6 Fluorescence Glycoprotein BEH Amide 2.1 x 150 mm FA4G4S4 FA4G4Lac1S4 FA4G4Lac2S4 N-Linked Glycans Released Glycan FA4G4Lac1S3 FA4G4S3 FA4G4Lac1S4+Ac FA4G4Lac2S3 FA4G4Lac3S3 FA2G2S , ppm FA4G4S4+Ac , ppm FA2G2S1 FA2G2S2 FA4G4S4+Ac FA3G3S3 FA4G4Lac3S4 FA4G4Lac4S4 0E+0 2E+5 BPI 890 m/z m/z 1349 FA4G4Lac2S4 FA4G4Lac4S , , ppm 0.9 ppm 0E m/z m/z Patent pending 2015 Waters Corporation 52
53 HILIC of Intact N-Deglycosylated EPO O-Linked Glycan Characterization 1E+7 Intr rinsic Fluo orescence Detection O-Linked Glycan O-Linked Glycan N-Linked Glycans Rapid Deglycosylation Intact 0E min Patent pending 2015 Waters Corporation 53
54 HILIC of Intact N-Deglycosylated EPO O-Linked Glycan Characterization Intr rinsic Fluo orescence Detection 1E+7 0E+0 Aglycosylated * O-Linked Glycan * * O-Linked Glycan PNGase F Da +TFA Da Da min kda +TFA +TFA Intact *Truncated C-terminus Patent pending 2015 Waters Corporation 54
55 Novel Widepore HILIC Column for Supporting Multiple Analysis Workflows Large Molecule HILIC ACQUITY UPLC Glycoprotein BEH Amide Column Intact Glycoprotein Glycan occupancy on intact mabs Profiling occupancy and heterogeneity of EPO O- glycosylation Middle-Up Middle-Down Subunits Rapid domain specific glycan profiling using IdeS digestion Higher quality MS of glycoforms Glycopeptides Glycopeptides Traditional proteolytic digestion to yield site-specific glycan profiling Patent pending 2015 Waters Corporation 55
56 Glycoprotein Performance Test Standard FLR RNase A Man5 Man7 RNase B Glycoforms System Suitability Troubleshooting Benchmarking Man6 Man8 Man9 N-Linked Glycans KETAA AKFER QHMDS STSAA SSSNY CNQMM KSRNL TIC TKDRC KPVNT FVHES LADVQ AVCSQ KNVAC KNGQT Disulfides NCYQS YSTMS ITDCR ETGSS KYPNC AYKTT QANKH IIVAC EGNPY VPVHF DASV Species M Average (Da) Aglycosylated (4 disulfides) RNase B (4 disulfides), Man Rnase B (4 disulfides), Man Rnase B (4 disulfides), Man Rnase B (4 disulfides), Man Rnase B (4 disulfides), Man Waters Corporation 56
57 gy 5+ New Application Notes on Glycoprotein BEH Amide 300Å Separations 2015 Waters Corporation 57
58 Thank You Released Glycan Analysis RapiFluor-MS Xevo G2-XS QTof ACQUITY QDa Detector Innovative Glycan Analyses ACQUITY UPLC Glycoprotein BEH Amide Column Intact Glycoprotein Glycopeptides Middle-Up Middle-Down Acknowledgements S. McCall S. Koza Y. Yu D. Brousmiche P. Iraneta B. Alden E. Chambers J. Fournier G. Mantha B. Warren W. Gu K. Wyndham 2015 Waters Corporation 58
59 Thank You for Attending! Post-Event Home Page: 20% Introductory Offer GlycoWorks RapiFluor-MS N-Glycan Analysis Kits 30% Introductory Offer All Glycan Columns and our NEW ACQUITY UPLC Glycoprotein BEH Amide 300Å 1.7 µm Columns Full Webinar Recording w/pdf Slide Deck Compilation of KEY Literature, Brochures etc For Questions and to Submit your Ideas for our Next Topic Please - mychemrep@waters.com 2015 Waters Corporation 59
Bringing Glycan Analysis to a New Age of Enlightenment
Bringing Glycan Analysis to a New Age of Enlightenment A discussion of disruptive LCMS technologies and workflows for released glycan and glycoprotein analysis. 2015 Waters Corporation 1 RapiFluor-MS:
More informationThe Road to Glycan Analysis Without Compromise WCBP 2015 Waters Technical Seminar Jan 27, 2015 Washington, DC
The Road to Glycan Analysis Without Compromise WCBP 2015 Waters Technical Seminar Jan 27, 2015 Washington, DC 2015 Waters Corporation 1 Today s Agenda Overview and Introduction RapiFluor-MS N-Glycan Labeling:
More informationApplying a Novel Glycan Tagging Reagent, RapiFluor-MS, and an Integrated UPLC-FLR/QTof MS System for Low Abundant N-Glycan Analysis
Applying a Novel Glycan Tagging Reagent, RapiFluor-MS, and an Integrated UPLC-FLR/QTof MS System for Low Abundant N-Glycan Analysis Ying Qing Yu Waters Corporation, Milford, MA, USA APPLICATION BENEFITS
More informationHILIC Glycopeptide Mapping with a Wide-Pore Amide Stationary Phase
Matthew A. Lauber and Stephan M. Koza Waters Corporation, Milford, MA, USA APPLICATION BENEFITS Orthogonal selectivity to conventional reversed phase (RP) peptide mapping for enhanced characterization
More informationThank you for joining us! Our session will begin shortly Waters Corporation 1
UPLC and HPLC Separation Strategies for Successful Characterization of Glycans Derived from Therapeutic Proteins Thank you for joining us! Our session will begin shortly 2013 Waters Corporation 1 Friendly
More informationCurrent Glycoprotein Analysis. Glycan Characterization: Oligosaccharides. Glycan Analysis: Sample Preparation. Glycan Analysis: Chromatography
Bio Day DENMARK MARCH 2013 Analysis of N-linked Glycans of GlycoProteins marleen_van_wingerden@waters.com Agenda Importance of Glycan Analysis Current Glycoprotein Analysis Glycan Characterization: Oligosaccharides
More informationCharged Surface Hybrid C18 for High Resolution LC and LC/MS Peptide Separations
Charged Surface Hybrid C18 for High Resolution LC and LC/MS Peptide Separations Higher Quality Peptide Separations Using Hybrid Particle-Based Reversed-Phase Columns and CSH Technology Matthew Lauber,
More informationAnalysis of N-Linked Glycans from Coagulation Factor IX, Recombinant and Plasma Derived, Using HILIC UPLC/FLR/QTof MS
Analysis of N-Linked Glycans from Coagulation Factor IX, Recombinant and Plasma Derived, Using HILIC UPLC/FLR/QTof MS Ying Qing Yu Waters Corporation, Milford, MA, U.S. A P P L I C AT ION B E N E F I T
More informationGlycoWorks Sample Preparation Consumables
GlycoWorks Sample Preparation Consumables Glycosylation is one of the most common forms of post-translational modification (PTM) of human and other eukaryotic proteins. Glycosylated proteins (glycolproteins)
More informationDr Mark Hilliard, NIBRT. Waters THE SCIENCE OF WHAT S POSSIBLE TM
RFMS Glycan Characterization Techniques for Biotherapeutics Dr Mark Hilliard, NIBRT Waters THE SCIENCE OF WHAT S POSSIBLE TM The Complexity of Glycosylation Glycosylation is the most common posttranslational
More informationCan we learn something new about peptide separations after 40 years of RP and HILIC chromatography? Martin Gilar April 12, MASSEP 2016
Can we learn something new about peptide separations after 40 years of RP and HILIC chromatography? Martin Gilar April 12, MASSEP 2016 2015 Waters Corporation 1 Overview 1. 2D RP RP LC of peptides 2. RP-LC
More informationRapid Preparation of Released N-Glycans for HILIC Analysis Using a Labeling Reagent that Facilitates Sensitive Fluorescence and ESI- MS Detection
Supporting Information for Rapid Preparation of Released N-Glycans for HILIC Analysis Using a Labeling Reagent that Facilitates Sensitive Fluorescence and ESI- MS Detection Matthew A. Lauber, 1 Ying-Qing
More informationN-Glycan Sequencing Kit
PROTEIN TOOLS N-Glycan Sequencing Kit Instruction Manual NEB #E577S 2 reactions Version 1. 1/18 be INSPIRED drive DISCOVERY stay GENUINE This product is intended for research purposes only. This product
More informationA Novel HILIC Column for High Speed N-linked Glycan Analysis
A Novel HILIC for High Speed N-linked Glycan Analysis Application Note Biotherapeutics and Biosimilars Authors James Martosella, Oscar Potter, Danny Mancheno, and Jia Liu Agilent Technologies, Inc. Introduction
More informationGlycan and Monosaccharide Workshop Eoin Cosgrave David Wayland Bill Warren
Glycan and Monosaccharide Workshop Eoin Cosgrave David Wayland Bill Warren 2012 Waters Corporation 1 Requests and Questions Optimised sample prep protocol to reduce sample preparation time How can I detect
More informationApplication Note. Abstract. Author. Biotherapeutics & Biosimilars. Sonja Schneider Agilent Technologies, Inc. Waldbronn, Germany
Sensitive and Reproducible Glycan Analysis of Human Immunoglobulin G The Agilent 1260 Infi nity Bio-inert Quaternary LC System with an Agilent AdvanceBio 2.7 µm Glycan Mapping Column and Fluorescence Detection
More informationThank you for joining us! Our session will begin shortly Waters Corporation 1
Thank you for joining us! Our session will begin shortly Strategies for Successful Characterization of N-Linked Oligosaccharides: Using HILIC Separation Method and the New GlycoWorks Sample Preparation
More informationComparison of Relative Quantification of Monoclonal Antibody N-glycans Using Fluorescence and MS Detection
Comparison of Relative Quantification of Monoclonal ntibody N-glycans Using Fluorescence and MS Detection pplication Note iotherapeutics & iologics uthors scar Potter and Gregory Staples gilent Technologies,
More informationOnline 2D-LC Analysis of Complex N-Glycans in Biopharmaceuticals Using the Agilent 1290 Infinity 2D-LC Solution
Online D-LC Analysis of Complex N-Glycans in Biopharmaceuticals Using the Agilent 19 Infinity D-LC Solution Comprehensive and Multiple Heart-Cutting D-LC Analysis for Highest Resolution Application Note
More informationCore-Shell Technology for Proteins and Peptides
Core-Shell Technology for Proteins and Peptides Better BioSeparations on HPLC and UHPLC Systems www.phenomenex.com/aeris Aeris Core-Shell Technology Core-Shell Particles Precision Engineered for Protein
More information[ CARE AND USE MANUAL ] GlycoWorks Single Use Sample Preparation Kit CONTENTS
GlycoWorks Single Use Sample Preparation Kit CONTENTS I. INTRODUCTION General Guideline of Sample Preparation from Glycoprotein to enrich FLR Labeled Glycans Using Reductive Amination Reaction. II. STORAGE
More informationDetailed Characterization of Antibody Glycan Structure using the N-Glycan Sequencing Kit
be INSPIRED drive DISCOVERY stay GENUINE APPLICATION NOTE Detailed Characterization of Antibody Glycan Structure using the N-Glycan Sequencing Kit Beth McLeod, New England Biolabs, Inc. Materials Remicade
More informationDevelopment of a Glycan Database for Waters ACQUITY UPLC Systems
Mark Hilliard, 1 Weston Struwe, 1 Barbara Adamczyk, 1 Radka Saldova, 1 Ying Qing Yu, 2 John O Rourke, 1 Giorgio Carta, 1 and Pauline Rudd 1 1 National Institute for Bioprocessing Research & Training (NIBRT),
More informationGlycanPac AXR-1 Columns
CHRMATGRAPHY GlycanPac AXR- Columns For High Resolution Glycan Analysis Product Specifications The Thermo Scientific GlycanPac AXR- columns are highperformance, silica-based HPLC columns for simultaneous
More informationRAPID SAMPLE PREPARATION METHODS FOR THE ANALYSIS OF N-LINKED GLYCANS
RAPID SAMPLE PREPARATION METHODS FOR THE ANALYSIS OF N-LINKED GLYCANS Zoltan Szabo, András Guttman, Tomas Rejtar and Barry L. Karger Barnett Institute, Boston, MA, USA PCT Workshop,Boston, 21 May, 2010.
More informationLudger Guide to Sialylation: II. Highly Sialylated Glycoproteins
Ludger Guide to Sialylation: II Highly Sialylated Glycoproteins Ludger has over 15 years experience providing products and services for the biopharmaceutical industry and in that time we have noticed that
More informationAeris. Precision Engineered Core- Shell Particles for Ultra-High Resolution BioSeparations. Aeris PEPTIDE. Aeris WIDEPORE
Aeris Precision Engineered Core- Shell Particles for Ultra-High Resolution BioSeparations Aeris is a specialized line of reversed phase core-shell UHPLC columns, built exclusively for the ultra-high performance
More informationLudgerPure TM APTS Labelled IgG Glycan Library
Certificate of Analysis LudgerPure TM APTS Labelled IgG Glycan Library Cat. #: CAPTS-IgG-0 Batch #. B-0 Size: approx. 0 pmol Description and: Source A mixture of APTS labelled fucosylated bi-antennary
More informationCharacterization of Disulfide Linkages in Proteins by 193 nm Ultraviolet Photodissociation (UVPD) Mass Spectrometry. Supporting Information
Characterization of Disulfide Linkages in Proteins by 193 nm Ultraviolet Photodissociation (UVPD) Mass Spectrometry M. Montana Quick, Christopher M. Crittenden, Jake A. Rosenberg, and Jennifer S. Brodbelt
More informationA NOVEL METHOD OF M/Z DRIFT CORRECTION FOR OA-TOF MASS SPECTROMETERS BASED ON CONSTRUCTION OF LIBRARIES OF MATRIX COMPONENTS.
A NOVEL METHOD OF M/Z DRIFT CORRECTION FOR OA-TOF MASS SPECTROMETERS BASED ON CONSTRUCTION OF LIBRARIES OF MATRIX COMPONENTS. Martin R Green*, Keith Richardson, John Chipperfield, Nick Tomczyk, Martin
More informationHigh Resolution Glycopeptide Mapping of EPO Using an Agilent AdvanceBio Peptide Mapping Column
High Resolution Glycopeptide Mapping of EPO Using an Agilent AdvanceBio Peptide Mapping Column Application Note BioPharma Authors James Martosella, Phu Duong, and Alex Zhu Agilent Technologies, Inc. Abstract
More informationIsomer Separation of Positively Labeled N-glycans by CE-ESI-MS
Isomer Separation of Positively Labeled N-glycans by CE-ESI-MS G.S.M. Kammeijer Center for Proteomics and Metabolomics CE IN THE BIOTECHNOLOGY & PHARMACEUTICAL INDUSTRIES 19 TH SYMPOSIUM ON THE PRACTICAL
More informationon Non-Consensus Protein Motifs Analytical & Formulation Sciences, Amgen. Seattle, WA
N-Linked Glycosylation on Non-Consensus Protein Motifs Alain Balland Analytical & Formulation Sciences, Amgen. Seattle, WA CASSS - Mass Spec 2010 Marina Del Rey, CA. September 8 th, 2010 Outline 2 Consensus
More informationSupplementary Materials for
advances.sciencemag.org/cgi/content/full/2/1/e1500678/dc1 Supplementary Materials for Chemical synthesis of erythropoietin glycoforms for insights into the relationship between glycosylation pattern and
More informationProfiling the Distribution of N-Glycosylation in Therapeutic Antibodies using the QTRAP 6500 System
Profiling the Distribution of N-Glycosylation in Therapeutic Antibodies using the QTRAP 6500 System Scheduled MRM Pro Algorithm for Increased Efficiency of Targeted Detection Jenny Albanese 1, Christie
More informationUsing LC-Based Technologies for Elucidating Complex Carbohydrate Structures
Using LC-Based Technologies for Elucidating Complex Carbohydrate Structures Eoin Cosgrave, PhD Formerly with NIBRT Glycobiology Group Currently Senior Scientist with Waters Biopharmaceutical Life Sciences
More informationDr. Erin E. Chambers Waters Corporation. Presented by Dr. Diego Rodriguez Cabaleiro Waters Europe Waters Corporation 1
Development of an SPE-LC/MS/MS Assay for the Simultaneous Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid in Support of Alzheimer s Research Dr. Erin E. Chambers Waters Corporation Presented
More informationCertificate of Analysis
Certificate of Analysis Human IgG Glycoprotein Standard Cat. #: GCP-IGG-50U Batch: B13T-06 Nominal size: 50μg Expiry: Dec 2020 Description: A glycoprotein standard for use during glycan release and labeling.
More informationA Definitive Lipidomics Workflow for Human Plasma Utilizing Off-line Enrichment and Class Specific Separation of Phospholipids
A Definitive Lipidomics Workflow for Human Plasma Utilizing Off-line Enrichment and Class Specific Separation of Phospholipids Jeremy Netto, 1 Stephen Wong, 1 Federico Torta, 2 Pradeep Narayanaswamy, 2
More informationAutomating Mass Spectrometry-Based Quantitative Glycomics using Tandem Mass Tag (TMT) Reagents with SimGlycan
PREMIER Biosoft Automating Mass Spectrometry-Based Quantitative Glycomics using Tandem Mass Tag (TMT) Reagents with SimGlycan Ne uaca2-3galb1-4glc NAcb1 6 Gal NAca -Thr 3 Ne uaca2-3galb1 Ningombam Sanjib
More informationHigh Throughput Accurate Mass Screening of Monoclonal Antibodies
High Throughput Accurate Mass Screening of Monoclonal Antibodies Jim Blasberg April 28, 211 sigma-aldrich.com Life Science and High Technology Center Life Science and High Technology Center2 Sigma-Aldrich,
More informationBiotherapeutics. Biopharmaceutical Sciences Group Waters Corporation Waters Corporation 1
Characterization of the Higher-Order Structure of Biotherapeutics Biopharmaceutical Sciences Group Waters Corporation 2011 Waters Corporation 1 FDA desire for specific innovations in biotherapeutic analysis
More informationDevelopment of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid
Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid Joanne ( 乔安妮 ) Mather Senior Scientist Waters Corporation Data courtesy of Erin Chambers and Mary
More information[ APPLICATION NOTE ] High Sensitivity Intact Monoclonal Antibody (mab) HRMS Quantification APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS
Yun Wang Alelyunas, Henry Shion, Mark Wrona Waters Corporation, Milford, MA, USA APPLICATION BENEFITS mab LC-MS method which enables users to achieve highly sensitive bioanalysis of intact trastuzumab
More informationBarry Boyes 1,2, Shujuan Tao 2, and Ron Orlando 2
Barry Boyes 1,2, Shujuan Tao 2, and Ron Orlando 2 1 Advanced Materials Technology, Inc. Wilmington, DE USA 2 Complex Carbohydrate Research Center University of Georgia, Athens, GA USA bboyes@advanced-materials-tech.com
More informationBiological Mass Spectrometry. April 30, 2014
Biological Mass Spectrometry April 30, 2014 Mass Spectrometry Has become the method of choice for precise protein and nucleic acid mass determination in a very wide mass range peptide and nucleotide sequencing
More informationThermo Fisher Scientific, Sunnyvale, CA, USA; 2 Thermo Fisher Scientific, San Jose, CA, USA
An Ultra High Resolution Glycan Column for Isomeric Separation and the Structural Identification of Labeled N-Glycans from Proteins Including Antibodies Udayanath Aich, 1 Julian Saba, 2 Rosa Viner, 2 Shanhua
More informationRapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer
Robert Plumb, Michael D. Jones, and Marian Twohig Waters Corporation, Milford, MA, USA INTRODUCTION The detection and characterization of impurities and degradation products of an active pharmaceutical
More informationA Fully Integrated Workflow for LC-MS/MS Analysis of Labeled and Native N-Linked Glycans Released From Proteins
A Fully Integrated Workflow for LC-MS/MS Analysis of Labeled and Native N-Linked Glycans Released From Proteins Udayanath Aich, 1 Julian Saba, 2 Xiaodong Liu, 1 Srinivasa Rao, 1 Yury Agroskin, 1 and Chris
More informationTECHNICAL BULLETIN. R 2 GlcNAcβ1 4GlcNAcβ1 Asn
GlycoProfile II Enzymatic In-Solution N-Deglycosylation Kit Product Code PP0201 Storage Temperature 2 8 C TECHNICAL BULLETIN Product Description Glycosylation is one of the most common posttranslational
More informationProbing for Packaging Migrants in a Pharmaceutical Impurities Assay Using UHPLC with UV and Mass Detection INTRODUCTION
Probing for Packaging Migrants in a Pharmaceutical Impurities Assay Using UHPLC with UV and Mass Detection Michael Jones Waters Corporation, Wilmslow, UK APPLICATION BENEFITS The ACQUITY Arc System is
More informationSeparation of 15 Underivatized Saccharide and Sialic Acid USP Standards
Application Note Raw Material & Media Analysis Separation of Underivatized Saccharide and Sialic Acid USP Standards Using an Agilent AdvanceBio MS Spent Media Column with TOF MS Detection Author Richard
More informationChemical Analysis Business Operations Waters Corporation Milford MA
The Detection and Identification of Unknown Contaminants During ToF Screening and Structural Elucidation for Pesticides in River Water Using an Integrated Software Approach Chemical Analysis Business Operations
More informationReducing Sample Volume and Increasing Sensitivity for the Quantification of Human Insulin and 5 Analogs in Human Plasma Using ionkey/ms
Reducing Sample Volume and Increasing Sensitivity for the Quantification of Human Insulin and 5 Analogs in Human Plasma Using ionkey/ms Erin E. Chambers and Kenneth J. Fountain Waters Corporation, Milford,
More informationSmall Molecule Science: Experimental designs for achieving ultra trace analysis
Small Molecule Science: Experimental designs for achieving ultra trace analysis Michael P. Balogh Principal scientist Waters Corporation 211 Waters Corporation 1 www.cosmoscience.org The Society for Small
More informationUsing Hydrophilic Interaction Chromatography (HILIC) for the Retention of Highly Polar Analytes
Using Hydrophilic Interaction Chromatography (HILIC) for the Retention of Highly Polar Analytes Eric S. Grumbach,, Diane M. Diehl and Jeffrey R. Mazzeo 2003 Waters Corp. Outline Introduction HILIC Definition
More informationThermo Scientific. GlycanPac AXR-1. Column Product Manual. P/N: April, Part of Thermo Fisher Scientific
Thermo Scientific GlycanPac AXR-1 Column Product Manual P/N: April, 2014 Part of Thermo Fisher Scientific Product Manual for GlycanPac AXR-1 Columns GlycanPac AXR-1, 1.9 µm, Analytical, 2.1 x 150 mm (P/N
More informationUPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes
UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes Catalin E. Doneanu, Weibin Chen, and Jeffrey R. Mazzeo Waters Corporation, Milford, MA, U.S. A P P L I C AT ION B E N E F
More informationNovel Glycan Column Technology for the LC-MS Analysis of Labeled and Native N-Glycans Released from Proteins and Antibodies
Novel Glycan Column Technology for the LC-MS Analysis of Labeled and Native N-Glycans Released from Proteins and Antibodies Udayanath Aich, 1 Ilze Birznieks, 1 Julian Saba, 2 Xiaodong Liu, 1 Rosa Viner,
More informationINTRODUCTION CH 3 CH CH 3 3. C 37 H 48 N 6 O 5 S 2, molecular weight Figure 1. The Xevo QTof MS System.
Fast and Sensitive in vitro Metabolism Study of Rate and Routes of Clearance for Ritonavir using UPLC CUPLED with the Xevo QTof MS System Jose Castro-Perez, Kate Yu, John Shockcor, Henry Shion, Emma Marsden-Edwards,
More informationSupporting information
Electronic Supplementary Material (ESI) for ChemComm. This journal is The Royal Society of Chemistry 2014 Supporting information Glycan Reductive Isotope-coded Amino Acid Labeling (GRIAL) for Mass Spectrometry-based
More informationFlow-Through Electron Capture Dissociation in a novel Branched RF Ion Trap
Flow-Through Electron Capture Dissociation in a novel Branched RF Ion Trap Takashi Baba, J. Larry Campbell, Yves Le Blanc, Jim. W. Hager and Bruce A. Thomson ASMS, June 18 / 2014 1 2014 AB SCIEX Trapping
More informationAPPLICATIONS Improving Intact Biogeneric Protein Separations with Aeris WIDEPORE Core-Shell Columns
Improving Intact Biogeneric Protein Separations with Aeris WIDEPORE Core-Shell Columns Michael McGinley, Deborah Jarrett, and Jeff Layne Phenomenex, Inc., 411 Madrid Avenue, Torrance, CA 91 USA Aeris WIDEPORE
More informationSeparation of 2AA-Labeled N-Linked Glycans from Glycoproteins on a High Resolution Mixed-Mode Column
Separation of 2AA-Labeled N-Linked Glycans from Glycoproteins on a High Resolution Mixed-Mode Column Udayanath Aich, Julian Saba, Xiaodong Liu, Jeff Rohrer, Jim Thayer and Chris Pohl, Thermo Fisher Scientific,
More informationOligosaccharide Analysis by High-Performance Anion- Exchange Chromatography with Pulsed Amperometric Detection
Oligosaccharide Analysis by High-Performance Anion- Exchange Chromatography with Pulsed Amperometric Detection Jeff Rohrer, Ph.D. Director, Applications Development, Dionex Products 1 The world leader
More informationExtended Mass Range Triple Quadrupole for Routine Analysis of High Mass-to-charge Peptide Ions
Extended Mass Range Triple Quadrupole for Routine Analysis of High Mass-to-charge Peptide Ions Application Note Targeted Proteomics Authors Linfeng Wu, Christine A. Miller, Jordy Hsiao, Te-wei Chu, Behrooz
More information[ APPLICATION NOTE ] Profiling Mono and Disaccharides in Milk and Infant Formula Using the ACQUITY Arc System and ACQUITY QDa Detector
Profiling Mono and Disaccharides in Milk and Infant Formula Using the ACQUITY Arc System and ACQUITY QDa Detector Mark Benvenuti, Gareth Cleland, and Jennifer Burgess Waters Corporation, Milford, MA, USA
More informationINLIGHT Glycan Tagging Kit Protocol
Cambridge Isotope Laboratories, Inc. isotope.com INLIGHT Glycan Tagging Kit Protocol A Glycan Tagging Kit for Comparative Quantification of N-linked Glycans INLIGHT Glycan Tagging Kit Catalog No. GTK-1000
More informationPr oducts List Ludger Ltd Culham Science Centre Oxford OX14 3EB United Kingdom
Pr oducts List 2018 Ludger Ltd Culham Science Centre Oxford OX14 3EB United Kingdom Email: lily.wang@ludger.com cindy.li@ludger.com www.ludger.com www.ludgersh.com Enzymes for Glycan Release E-PNG01 PNGase
More informationSMART Digest Kit Facilitating perfect digestion
Questions Answers SMART Digest Kit Facilitating perfect digestion The modern biopharmaceutical and protein research laboratory is tasked with providing high quality analytical results, often in high-throughput,
More informationSupporting Information Parsimonious Charge Deconvolution for Native Mass Spectrometry
Supporting Information Parsimonious Charge Deconvolution for Native Mass Spectrometry Marshall Bern* 1, Tomislav Caval 2, Yong J. Kil 1, Wilfred Tang 1, Christopher Becker 1, Eric Carlson 1, Doron Kletter
More informationUltra Columns HPLC COLUMNS
Acetaminophen, Narcotic Analgesics.............519 Aldehydes, Ketones...........................500 Beclomethasone.............................523 Corticosteroids..............................529 Explosives..................................501
More informationO O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions
Simplifying Qual/Quan Analysis in Discovery DMPK using UPLC and Xevo TQ MS Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION The determination of the drug metabolism
More informationCE in biopharma science: it s more than GCE and cief Unexploited applications from the sewing box
CE in biopharma science: it s more than GCE and cief Unexploited applications from the sewing box CEPharm 2018, PD Dr. Maria A. Schwarz and Dr. Samuel Bader 12.09.2018 Introduction It s more than GCE and
More informationSeQuant ZIC -HILIC For all who expect more...
SeQuant ZIC -ILIC For all who expect more... The better choice for PLC and LC/MS of all types of polar and hydrophilic compounds EMD Millipore is a division of Merck KGaA, Darmstadt, Germany Poor retention
More informationAccuMAP Low ph Protein Digestion Kits
TECHNICAL MANUAL AccuMAP Low ph Protein Digestion Kits Instruc ons for Use of Products VA1040 and VA1050 5/17 TM504 AccuMAP Low ph Protein Digestion Kits All technical literature is available at: www.promega.com/protocols/
More informationLC/MS Analysis of Various Hydrophilic Compounds Using a Polymer-Based Amino Column - Shodex TM HILICpak TM VG-50 2D
LC/MS Analysis of Various Hydrophilic Compounds Using a Polymer-Based Amino Column - Shodex TM HILICpak TM VG-50 2D Introduction Components of pharmaceutical products and food products often include high
More informationHICHROM. Chromatography Columns and Supplies NEW PRODUCTS. Catalogue 9. Hichrom Limited
HICHROM Chromatography Columns and Supplies NEW PRODUCTS Catalogue 9 1 The Markham Centre, Station Road Theale, Reading, Berks, RG7 4PE, UK Tel: +44 (0)118 930 3660 Fax: +44 (0)118 932 3484 Email: sales@hichrom.co.uk
More informationFast Separation of Triacylglycerols in Oils using UltraPerformance Convergence Chromatography (UPC 2 )
Fast Separation of Triacylglycerols in Oils using UltraPerformance Convergence Chromatography (UPC 2 ) Mehdi Ashraf-Khorassani, 1 Larry T. Taylor, 1 Jinchuan Yang, 2 and Giorgis Isaac 2 1 Department of
More informationAdvantages of Ion Mobility Q-TOF for Characterization of Diverse Biological Molecules
Advantages of Ion Mobility Q-TOF for Characterization of Diverse Biological Molecules Add a New Dimension to your Research Capability with Agilent s New Drift Ion Mobility Q-TOF System Overview: 6560 IM
More informationDetailed Analysis of Polyclonal IgG with Emphasis on Sialylation and Sub-Classes After Fractionation on a Sialic-Acid Binding Lectin
Universität für Bodenkultur Wien Institute of Biochemistry Detailed Analysis of Polyclonal IgG with Emphasis on Sialylation and Sub-Classes After Fractionation on a Sialic-Acid Binding Lectin by Friedrich
More informationMass Spectrometry at the Laboratory of Food Chemistry. Edwin Bakx Laboratory of Food Chemistry Wageningen University
Mass Spectrometry at the Wageningen University Mass Spectrometry at the 3 UPLC/CE - ESI - Ion trap MS systems UPLC Thermo Acella with a Velos or VelosPro CE Beckman PA800 with a Thermo VelosPro 1 UPLC-
More informationFetuin Glycoprotein Standard
Certificate of Analysis Fetuin Glycoprotein tandard Cat. #: GCP-FET-U-X (GCP-FET-U B7K- *) Batch: BC- Nominal size: * μg Expiry Date: Apr Description: A glycoprotein standard for use during glycan release
More informationSeQuant ZIC -HILIC For all who expect more...
SeQuant ZIC -ILIC For all who expect more... The better choice for PLC and LC/MS of all types of polar and hydrophilic compounds EMD Millipore Corp. is a subsidiary of Merck KGaA, Darmstadt, Germany Poor
More informationUltra Columns. also available. ordering note
: 3μm or 5μm particles; 100Å pore size Our broadest selection of stationary phases, including unique phases. High density bondings, for maximum retention. High-purity, Type B silica gives excellent peak
More informationProfiling Flavonoid Isomers in Highly Complex Citrus Juice Samples Using UPLC Ion Mobility Time-of-Flight Mass Spectrometry
Profiling Flavonoid Isomers in Highly Complex Citrus Juice Samples Using UPLC Ion Mobility Time-of-Flight Mass Spectrometry Michael McCullagh, 1 Kieran Neeson, 2 and Antonietta Gledhill 1 Waters Corporation,
More information2012 Waters Corporation 1
An Introduction to Waters HPLC and ACQUITY UPLC Column Technologies for small molecule analysis Esa Lehtorinne Esa_Lehtorinne@waters.com Tel: +358-9-5659 5659 6288 Fax: +358-9-5659 5659 6282 Waters Finland
More informationApplication Note # ET-17 / MT-99 Characterization of the N-glycosylation Pattern of Antibodies by ESI - and MALDI mass spectrometry
Bruker Daltonics Application Note # ET-17 / MT-99 Characterization of the N-glycosylation Pattern of Antibodies by ESI - and MALDI mass spectrometry Abstract Analysis of the N-glycosylation pattern on
More informationChallenges in Separation Technologies
Challenges in Separation Technologies Erin Shammel Baker Xing Zhang, Yehia Ibrahim, Matthew Monroe, Dennis Mehinagic, Justin Teeguarden, Thomas Metz and Richard D. Smith Pacific Northwest National Laboratory
More informationNature Biotechnology: doi: /nbt Supplementary Figure 1
Supplementary Figure 1 The timeline of the NGAG method for extraction of N-linked glycans and glycosite-containing peptides. The timeline can be changed based on the number of samples. Supplementary Figure
More informationRapid Lipid Profiling of Serum by Reverse Phase UPLC-Tandem Quadrupole MS
Rapid Lipid Profiling of Serum by Reverse Phase UPLC-Tandem Quadrupole MS Mark Ritchie and Evelyn Goh Waters Pacific Pte Ltd., Singapore A P P L I C AT ION B E N E F I T S Delivers a rapid 10-min MRM method
More informationSeparation of Macrocyclic Lactones (Avermectins) on FLARE C18 MM & FLARE C18+ Columns
Separation of Macrocyclic Lactones (Avermectins) on FLARE C8 MM & FLARE C8+ Columns Introduction Diamond Analytics Technical Note: T05- Avermectins are a series of 6-membered macrocyclic lactone derivatives
More informationRun glycans up to 5x faster than HILIC
FAST GLYCAN LABELING AND ANALYSIS TECHNOLOGY Run glycans up to 5x faster than HILIC HI-RES ANALYSIS AND ID IN MINUTES Run Your Glycans in Record Time High-Resolution Glycan Identification and Quantitation
More informationStructural Analysis of Labeled N-Glycans from Proteins by LC-MS/MS Separated Using a Novel Mixed-Mode Stationary Phase
Structural Analysis of Labeled N-Glycans from Proteins by LC-MS/MS Separated Using a Novel Mixed-Mode Stationary Phase Udayanath Aich 1, Julian Saba 2, Xiaodong Liu 1, Srinivasa Rao 1, and Chris Pohl 1
More informationMatrix Factor Determination with the Waters Regulated Bioanalysis System Solution
Matrix Factor Determination with the Waters Regulated Bioanalysis System Solution Joanne Mather, Steve Cubbedge, Debadeep Bhattacharya, and Robert S. Plumb Waters Corporation, Milford, MA, U.S. A P P L
More informationUnbiased in-depth characterization of CEX fractions from a stressed mab by MS. Matthias Berg, Novartis Pharma, BTDM
Unbiased in-depth characterization of CEX fractions from a stressed mab by MS Matthias Berg, Novartis Pharma, BTDM Characterization of CEX fractions Biopharmaceuticals like IgGs show a certain degree of
More informationStudy of On-Resin Convergent Synthesis of N-Linked. Glycopeptides Containing a Large High Mannose N- Linked Oligosaccharide
Supporting Information Study of On-Resin Convergent Synthesis of N-Linked Glycopeptides Containing a Large High Mannose N- Linked Oligosaccharide Rui Chen and Thomas J. Tolbert* Department of Chemistry,
More informationProducts Price List. Euros Ludger Ltd Culham Science Centre Oxford OX14 3EB United Kingdom
Products Price List Euros 2018 Ludger Ltd Culham Science Centre Oxford OX14 3EB United Kingdom Tel: +44 1865 408 554 Fax: +44 870 163 4620 Email: info@ludger.com www.ludger.com Enzymes for Glycan Release
More informationBioanalytical Quantitation of Biotherapeutics Using Intact Protein vs. Proteolytic Peptides by LC-HR/AM on a Q Exactive MS
Bioanalytical Quantitation of Biotherapeutics Using Intact Protein vs. Proteolytic Peptides by LC-HR/AM on a Q Exactive MS Jenny Chen, Hongxia Wang, Zhiqi Hao, Patrick Bennett, and Greg Kilby Thermo Fisher
More informationWaters Amide Column Technology For Food Analysis
Waters Amide Column Technology For Food Analysis Euan Ross Business Development Manager Chemistry perations Europe 2012 Waters Corporation 1 verview verview of HILIC Retention mechanisms and characteristics
More information